Estrella Immunopharma, Inc. Common Stock
$0.53
Market Cap
$22.88M
Shares Outstanding
43.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 2, 2023
Round Lot
100
Locale
US
Day Open
$0.57
Day High
$0.58
Day Low
$0.51
Volume
57.7K
VWAP
$0.53
Prev Close
$0.53
Transactions
--
Acc. Volume
--
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Estrella Immunopharma, Inc. Common Stock (ESLA) closed the 2026-09-18 session at $0.53, up 0.57% versus the previous close (+0.00). The stock opened at $0.57 and traded between $0.51 and $0.58 during that session. Session trading volume was 58K shares. The volume-weighted average price (VWAP) is $0.53.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Estrella Immunopharma, Inc. Common Stock has a market capitalization of $22.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ESLA is listed on the XNAS exchange. Estrella Immunopharma, Inc. Common Stock is headquartered in EMERYVILLE, CA. The recorded listing date is 2023-10-02.
On this page you can find market ESLA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.